Quantitative analysis of bcl-2 expression in normal and leukemic human B-cell differentiation
✍ Scribed by Almeida, J; de Santiago, M; López, A; Roa, S; San Miguel, J F; Orfao, A; Menendez, P; Vargas, A; Bueno, C; Barrena, S
- Book ID
- 110055756
- Publisher
- Nature Publishing Group
- Year
- 2004
- Tongue
- English
- Weight
- 213 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0887-6924
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Background: In a previous work, we demonstrated with flow cytometry (FCM) methods that accumulation of human cyclin B1 in leukemic cell lines begins during the G 1 phase of the cell cycle (Viallard et al., Exp Cell Res 247: 208-219, 1999). In the present study, FCM was used to compare the localizati
## Abstract ## BACKGROUND Antiapoptotis resulting from hyperactivation of the transcription factor NF‐κB has been described in several cancer types. It is triggered by the interaction of the tumor necrosis factor (TNF) with its receptors and recruitment of the intermediate factor TNF‐receptor asso
## Background: Inhibition of apoptosis, or programmed cell death, may be critical both in the development of cancer and in determining response to therapy. the authors examined the expression of two related apoptotic inhibitors, bcl-2 and bcl-xl, in pretreatment biopsies from a series of 42 patient